
Dutch biopharma development firm Pharming has named Dr Perry Calias as the company’s chief scientific officer. Calias will have overall …
Dutch biotechnology group Pharming has signed a toll manufacturing agreement with Sanofi Chimie in order to boost commercial-scale manufacturing of …
Dutch biotech company Pharming has suffered a blow, after its lead product Rhucin was rejected by European regulators for a …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

